首页 | 本学科首页   官方微博 | 高级检索  
     

万拉法新与帕罗西汀治疗抑郁症的对比研究
引用本文:陈海支,陈胜华,李新胜,林敬华. 万拉法新与帕罗西汀治疗抑郁症的对比研究[J]. 医药导报, 2001, 20(8): 488-489
作者姓名:陈海支  陈胜华  李新胜  林敬华
作者单位:湖北省十堰市东风公司茅箭医院精神科
摘    要:目的:比较万拉法新与帕罗西汀治疗抑郁症的疗效和安全性。方法:将68例患者随机分为两组,分别给予万拉法新及帕罗西汀治疗,于治疗前及治疗后1,2,4,6周末分别用汉密尔顿抑郁量表(HAMD)、临床疗效总评量表(CGI-SI)及不良反应量表(TESS)评定。结果:第2周末两组间HAMD评分差异有显著性(P<0.05)。两组总有效率及副作用差异无显著性(P>0.05)。结论:万拉法新抗抑郁作用起效较快,疗效及副作用与帕罗西汀相当。

关 键 词:万拉法新 帕罗西汀 抑郁症 药物疗法 治疗 对比研究
文章编号:1004-0781(2001)08-0488-02
修稿时间:2000-11-08

A Controlled Study of the Efficacy of Venlafaxin Capsules and Paroxetine Tabletsin the Treatment of Depression
CHEN Hai-zhi,CHEN Sheng-hua,LI Xin-sheng,LIN Jin-hua. A Controlled Study of the Efficacy of Venlafaxin Capsules and Paroxetine Tabletsin the Treatment of Depression[J]. Herald of Medicine, 2001, 20(8): 488-489
Authors:CHEN Hai-zhi  CHEN Sheng-hua  LI Xin-sheng  LIN Jin-hua
Abstract:Objective:To compare the efficacy and safety of venlafaxine capsules and paroxetine tablets in the treatment of depression. Methods:68 subjects with depression were randomly divided into two groups and treated with venlafaxine capsules or paroxetine tablets, respectively, for 6 weeks. HAMD, CGL-SI, and TESS were used to evalate the patients at the 1st, 2nd, 4th and 6th week post-treatment. Result:The therapeutic efficacy was significantly different between the two groups(P<0.05). Conclusions:Venlafaxine capsule was a quicker agent than paroxetine tablet in respect of its effect. Both venlafaxine capsules and paroxetine tablets were effective and safe for the treatment of patients with depression.
Keywords:Venlafaxine  Paroxetine  Depression  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号